Isogloiosiphone B, a novel acetal, and hydrophobic compounds as β-glucuronidase inhibitors derived from the red alga Neodilsea yendoana
暂无分享,去创建一个
[1] Qurat-Ul-Ain,et al. Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives. , 2017, European journal of medicinal chemistry.
[2] N. Ismail,et al. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors. , 2015, Bioorganic chemistry.
[3] J. N. Kumar,et al. Catalytic Aerobic Oxidation of Alcohols using Recoverable IAPNO α‐Hydrogen Nitroxyl Radicals , 2015 .
[4] M. Choudhary,et al. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. , 2014, Bioorganic & medicinal chemistry.
[5] J. Zachary,et al. Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity. , 2014, The Journal of clinical investigation.
[6] S. Saeidnia,et al. Sterols from the red algae, Gracilaria salicornia and Hypnea flagelliformis, from Persian Gulf , 2011, Pharmacognosy magazine.
[7] H. Kurihara,et al. β-Glucuronidase Inhibitory Activity of Bromophenols Purified from Grateloupia elliptica , 2008 .
[8] M. Court,et al. Effect of the β‐glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP‐glucuronosyltransferases , 2008, The Journal of pharmacy and pharmacology.
[9] H. W. Scheeren,et al. Beta-glucuronidase-mediated drug release. , 2002, Current pharmaceutical design.
[10] J. Backman,et al. The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in Humans , 1997 .
[11] Y. Matsuo,et al. Yendolipin, a Novel Lipobetaine with an Inhibitory Activity Toward Morphogenesis in a Foliaceous Green Alga Monostroma oxyspermum. , 1997 .
[12] Minoru Suzuki,et al. An allelopathic polyunsaturated fatty acid from red algae , 1996 .
[13] W. Gerwick,et al. Gloiosiphones A and B, novel metabolites from the red marine alga Gloiosiphonia verticillaris , 1993 .
[14] H. Ohta,et al. Serum immunoreactive beta-glucuronidase determined by an enzyme-linked immunosorbent assay in patients with hepatic diseases. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[15] J. Clardy,et al. Laurencione, a heterocycle from the red alga Laurencia spectabilis , 1992 .
[16] V. Chapman,et al. The egasyn gene affects the processing of oligosaccharides of lysosomal beta-glucuronidase in liver. , 1986, The Biochemical journal.
[17] S. Hatanaka,et al. Sulfur-containing Amino Acids in Nature , 1977 .
[18] R. Jacox,et al. Variations of beta glucuronidase concentration in abnormal human synovial fluid. , 1955, The Journal of clinical investigation.
[19] G. A. Levvy,et al. Glucuronide Decomposition in the Digestive Tract , 1952, Nature.
[20] J. Backman,et al. The role of beta-glucuronidase in drug disposition and drug targeting in humans. , 1997, Clinical pharmacokinetics.
[21] I. Tannock,et al. Lysosomes, lysosomal enzymes, and cancer. , 1993, Advances in cancer research.
[22] J. Cabezas,et al. Properties of two molecular forms of beta-glucuronidase from the mollusc Littorina littorea L. , 1979, European journal of biochemistry.
[23] R. Cutler,et al. Failure of urinary beta-glucuronidase activity to localize the site of urinary tract infection. , 1971, Applied microbiology.
[24] M. Kuriyama. NINHYDRIN REACTIVE SUBSTANCES IN MARINE ALGAE-III , 1961 .